The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 12, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 7
- +2 vs. Q2 2021
- Portfolio value
- $879.1M
- +$172.6M (+24.4%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NGMNGM Biopharmaceuticals Inc | COM | 15,396,116 | $323.6M | 36.8% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $194.1M | 22.1% | +9,400,290 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 4,768,181 | $99.7M | 11.3% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 3,347,245 | $92.1M | 10.5% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 9,248,129 | $65.5M | 7.4% | +9,248,129 | New | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,309,329 | $60.5M | 6.9% | +4,309,329 | New | History |
| RAPTRAPT Therapeutics, Inc. | COM | 1,402,008 | $43.5M | 5.0% | −2,483,671−63.9% | Reduced | History |
Sold out since Q2 2021 (1)
Positions held at the end of Q2 2021 that are gone from this filing.